The trademark application JORELEV was filed by AstraZeneca AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on May 12, 2008, and it was registered by office on November 20, 2008 without any oppositions.
The application was filed in Swedish (English was selected as the second language).
The renewal of the trademark was recorded by the office on October 21, 2018.
of the trademark registration was recorded on October 21, 2018. Change of name and address of the trademark registration was recorded on October 24, 2009. Appointment and Replacement of representative of the trademark registration was recorded on September 18, 2018.